Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator

Positive results in pre-clinical studies of the triple combination of elexacaftor, tezacaftor and ivacaftor, performed in airway epithelial cell cultures obtained from patients harbouring the class II cystic fibrosis transmembrane conductance regulator (CFTR) mutation F508del-CFTR, translated to imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Laselva, Onofrio, Bartlett, Claire, Gunawardena, Tarini N.A., Ouyang, Hong, Eckford, Paul D.W., Moraes, Theo J., Bear, Christine E., Gonska, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209484/
https://www.ncbi.nlm.nih.gov/pubmed/33303536
http://dx.doi.org/10.1183/13993003.02774-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209484/
https://www.ncbi.nlm.nih.gov/pubmed/33303536
http://dx.doi.org/10.1183/13993003.02774-2020

Ejemplares similares